Medicina Legal, Psiquiatría y Patología
Departamento
Mutua de Terrassa
Terrassa, EspañaPublicaciones en colaboración con investigadores/as de Mutua de Terrassa (16)
2022
-
Genetic and phenotypic characterisation of HIV-associated aggressive B-cell non-Hodgkin lymphomas, which do not occur specifically in this population: diagnostic and prognostic implications
Histopathology, Vol. 81, Núm. 6, pp. 826-840
-
Novel genes and sex differences in COVID-19 severity
Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806
-
Sex and substance use in first episode psychosis: Impact on clinical symptoms, psychosocial functioning and cognitive performance
Revista de Psiquiatria y Salud Mental
2021
-
Bumetanide Oral Liquid Formulation for the Treatment of Children and Adolescents with Autism Spectrum Disorder: Design of Two Phase III Studies (SIGN Trials)
Journal of Autism and Developmental Disorders, Vol. 51, Núm. 8, pp. 2959-2972
-
Correction to: Bumetanide Oral Liquid Formulation for the Treatment of Children and Adolescents with Autism Spectrum Disorder: Design of Two Phase III Studies (SIGN Trials) (Journal of Autism and Developmental Disorders, (2021), 51, 8, (2959-2972), 10.1007/s10803-020-04709-8)
Journal of Autism and Developmental Disorders
-
Demographic, clinical, and functional determinants of antithrombotic treatment in patients with nonvalvular atrial fibrillation
BMC Cardiovascular Disorders, Vol. 21, Núm. 1
2018
-
Candida periprosthetic joint infection: A rare and difficult-to-treat infection
Journal of Infection, Vol. 77, Núm. 2, pp. 151-157
2017
-
The not-so-good prognosis of streptococcal periprosthetic joint infection managed by implant retention: The results of a large multicenter study
Clinical Infectious Diseases, Vol. 64, Núm. 12, pp. 1742-1752
2014
-
Cluster-randomized, controlled 12-month trial to evaluate the effect of a parental psychoeducation program on medication persistence in children with attention-defcit/hyperactivity disorder
Neuropsychiatric Disease and Treatment, Vol. 10, pp. 1081-1092
2011
-
Composite anatomical-clinical-molecular prognostic model in nonsmall cell lung cancer
European Respiratory Journal, Vol. 37, Núm. 1, pp. 136-142
2005
-
Safety and effectiveness of olanzapine in monotherapy: A multivariate analysis of a naturalistic study
Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 29, Núm. 6, pp. 944-951
-
Safety, effectiveness, and patterns of use of olanzapine in acute schizophrenia: A multivariate analysis of a large naturalistic study in the hospital setting
Medicina Clinica, Vol. 124, Núm. 13, pp. 481-486
2003
-
Safety and effectiveness of olanzapine versus conventional antipsychotics in the acute treatment of first-episode schizophrenic inpatients
Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 27, Núm. 3, pp. 473-481
-
Safety of olanzapine versus conventional antipsychotics in the treatment of patients with acute schizophrenia. A naturalistic study
European Neuropsychopharmacology, Vol. 13, Núm. 1, pp. 39-48
2001
-
Incidence of extrapyramidal symptoms during treatment with olanzapine, haloperidol and risperidone: Results of an observational study (EFESO study)
Actas Espanolas de Psiquiatria, Vol. 29, Núm. 1, pp. 25-32